(HealthDay)—It seems like common sense for people who've had COVID-19 to think they now have natural immunity, and therefore don't have to bother getting vaccinated.
Sep 27, 2021
0
18
Breast cancers expressing the protein HER2 have a particularly poor prognosis. Treatment with trastuzumab (Herceptin) benefits some patients with HER2-positive breast cancer, but it is not as effective as had been hoped. ...
Feb 13, 2012
0
0
In the fight against the coronavirus, one key component of the human immune system has hogged the limelight: antibodies.
Dec 17, 2021
0
32
Research led by St. Jude Children's Research Hospital scientists has identified a possible new approach to defeating bacterial infections by targeting an innate immune system component in a bid to invigorate the immune response.
Jul 2, 2012
0
0
An international consortium that includes researchers at Karolinska Institutet has developed a double antibody that targets two sites of the SARS-CoV-2 virus, thereby preventing the virus from mutating to resist the therapy. ...
Mar 25, 2021
0
292
Our immune system's arsenal of defenses usually protects us from cancer. But sometimes, cancer cells overwhelm or evade this elaborate defense system.
May 30, 2018
0
63
The Wistar Institute's David B. Weiner and collaborators have engineered novel monoclonal antibodies that engage natural killer (NK) cells through a unique surface receptor that activates the immune system to fight against ...
Nov 1, 2023
0
21
The American College of Physicians issued an updated Rapid, Living Practice Points on the antibody response to SARS-CoV-2 after initial infection and protection against reinfection with SARS-CoV-2. The new version, "What ...
Jan 26, 2022
0
10
In a breakthrough study to be published on the December 4th issue of the prestigious scientific journal Cell, a research team led by Miguel Soares at the Instituto Gulbenkian de Ciência (IGC; Portugal) discovered that specific ...
Dec 4, 2014
0
0
Scientists at the University of Southampton are to investigate the best way to use natural killer cells (NK) to target the most common form of liver cancer.
Oct 12, 2012
0
0
